Cited by 2,299Cancer Cells and MetastasisTGF-β signaling in diseasesCell Adhesion Molecules Research

The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.

Biomarkers for epithelial-mesenchymal transitions

Open access

Zeisberg, Michael, Neilson, Eric G.·2009·Journal of Clinical Investigation

Open this paper in CoChat — free account Open PDF

Abstract

Somatic cells that change from one mature phenotype to another exhibit the property of plasticity. It is increasingly clear that epithelial and endothelial cells enjoy some of this plasticity, which is easily demonstrated by studying the process of epithelial-mesenchymal transition (EMT). Published reports from the literature typically rely on ad hoc criteria for determining EMT events; consequently, there is some uncertainty as to whether the same process occurs under different experimental conditions. As we discuss in this Personal Perspective, we believe that context and various changes in plasticity biomarkers can help identify at least three types of EMT and that using a collection of criteria for EMT increases the likelihood that everyone is studying the same phenomenon - namely, the transition of epithelial and endothelial cells to a motile phenotype.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci36183

Cites

124 of 124 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M. W., Reinhard, F., Zhang, C. C., Shipitsin, M. V., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,839
Fibroblasts in cancer
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Self-citation
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Complex networks orchestrate epithelial–mesenchymal transitions
Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,947
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R., Côme, C., Savagner, P., Gitelman, I., Richardson, A. L., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,917
The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew‐Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,852
Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis
Yang, J., & Weinberg, R. A. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.05.009 · Cited by 3,079
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci20530 · Cited by 2,715
Self-citation
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
Ma, L., Teruya-Feldstein, J., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06174 · Cited by 2,605

Flagged first, then by citations

Show all 124 references

Research works printed but not linked: 8

Kalluri, 2003, J. Clin. Invest., 112, 1776, 10.1172/JCI200320530 · DOI
Xue, 2003, Cancer Res., 63, 3386
Colwell, 2005, Adv. Biochem. Eng. Biotechnol., 93, 83
Sommers, 1989, Cancer Res., 49, 4258
Wernert, 2001, Anticancer Res., 21, 2259
Higgins, 2007, J. Clin. Invest., 117, 3810
Bates, 2005, J. Clin. Invest., 115, 339, 10.1172/JCI200523183 · DOI
Gabbiani, 1981, Am. J. Pathol., 104, 206

Sorted by citations

Items 201–300 of 1,004

Epithelial-mesenchymal transition in liver fibrosis
ZHAO, Y.-L., Zhu, R., & SUN, Y.-L. (2016) · Biomedical Reports · doi:10.3892/br.2016.578 · Cited by 125
IGF-IR signaling in epithelial to mesenchymal transition and targeting IGF-IR therapy: overview and new insights
Li, H., Batth, I. S., Qu, X., Xu, L., Song, N., Wang, R., & Liu, Y. (2017) · Molecular Cancer · doi:10.1186/s12943-016-0576-5 · Cited by 125
“pathological response, EMT is involved in organ degeneration, such as fibrosis [47].”
Background
CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways
Nakamura, K., Terai, Y., Tanabe, A., Ono, Y. J., Hayashi, M., Maeda, K., Fujiwara, S., Ashihara, K., Nakamura, M., Tanaka, Y., et al. (2017) · Oncology Reports · doi:10.3892/or.2017.5583 · Cited by 121
“The epithelial-mesenchymal-transition (EMT) is a developmental process in which polarized epithelial cells undergo multiple biochemical changes and assume a mesenchymal phenotype, with increased migratory capacity, invasiveness, resistance to apoptosis and the expression of extracellular matrix components (2-6).”
Background
EGF-receptor signaling and epithelial-mesenchymal transition in human carcinomas
Moustafa, A. A. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s292 · Cited by 122
HIF ‐1α regulates EMT via the Snail and β‐catenin pathways in paraquat poisoning‐induced early pulmonary fibrosis
Zhu, Y., Tan, J., Xie, H., Wang, J., Meng, X., & Wang, R. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12769 · Cited by 123
“In tumours, HIF-1a promoted the expression of transforming growth factor (TGF)-b, LOX, Snail, TWIST-1, TCF-3, ZEB1 (Zinc finger E-box-binding homeobox 1) and ZEB2, which then activated EMT and the metastasis of tumour cells [31–34].”
Background
Short-chain fatty acid receptors inhibit invasive phenotypes in breast cancer cells
Thirunavukkarasan, M., Wang, C., Rao, A., Hind, T., Teo, Y. L., Siddiquee, A. A.-M., Goghari, M. A. I., Kumar, A. P., & Herr, D. R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186334 · Cited by 124
Lipid Peroxidation, GSH Depletion, and SLC7A11 Inhibition Are Common Causes of EMT and Ferroptosis in A549 Cells, but Different in Specific Mechanisms
Sun, L., Dong, H., Zhang, W., Wang, N., Ni, N., Bai, X., & Liu, N. (2020) · DNA and Cell Biology · doi:10.1089/dna.2020.5730 · Cited by 121
“…2009; Krenning et al. , 2010; Biernacka et al. , 2011; Jonsdottir et al. , 2015; Tian et al. , 2017). a -SMA, a cytoskeletal marker protein, is the principal secreted protein of myoﬁbroblasts responsible for tissue remodeling and ﬁbrogenesis (Neilson and Zeisberg, 2009; Bartis et al. , 2014).”
Role of COX-2/PGE2 Mediated Inflammation in Oral Squamous Cell Carcinoma
Nasry, W. H. S., Rodriguez-Lecompte, J. C., & Martin, C. K. (2018) · Cancers · doi:10.3390/cancers10100348 · Cited by 123
“E-cadherin is the most important intercellular adhesion molecule in epithelial cells and has a critical role in reducing invasive behaviours of cancer cells [103].”
Background
HNF4α regulates sulfur amino acid metabolism and confers sensitivity to methionine restriction in liver cancer
Xu, Q., Li, Y., Gao, X., Kang, K., Williams, J. G., Tong, L., Liu, J., Ji, M. H., Deterding, L. J., Tong, X., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17818-w · Cited by 116
Molecular Changes Underlying Hypertrophic Scarring Following Burns Involve Specific Deregulations at All Wound Healing Stages (Inflammation, Proliferation and Maturation)
Čoma, M., Fröhlichová, L., Urban, L., Zajíček, R., Urban, T., Szabó, P., Novak, S., Fetissov, V., Dvořánková, B., Smetana, K., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020897 · Cited by 124
“The process of EMT in keratinocytes is initiated by the loss of tight junctions followed by E-cadherin (epithelial marker) switch to N-cadherin (mesenchymal marker) [97].”
Background
Cyr61/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesis
Haque, I., Mehta, S., Majumder, M., Dhar, K., De, A., McGregor, D., Van Veldhuizen, P. J., Banerjee, S. K., & Banerjee, S. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-8 · Cited by 113
“An EMT event is involved in the formation of motile cells from parent epithelial cells that are not themselves motile [21].”
Background
Snail Promotes Epithelial Mesenchymal Transition in Breast Cancer Cells in Part via Activation of Nuclear ERK2
Smith, B., Burton, L. J., Henderson, V., Randle, D. D., Morton, D. J., Smith, B. A., Taliaferro-Smith, L. D., Nagappan, P., Yates, C. C., Zayzafoon, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104987 · Cited by 117
“poor prognosis and cancer cell growth [2,29].”
BackgroundInfluential
Dedifferentiation of Immortalized Human Podocytes in Response to Transforming Growth Factor-β
Herman‐Edelstein, M., Thomas, M. C., Thallas‐Bonke, V., Saleem, M. A., Cooper, M. E., & Kantharidis, P. (2011) · Diabetes · doi:10.2337/db10-1110 · Cited by 117
“However, what is occurring in podocytes in vitro or in vivo is not classic EMT, as recently defined by Zeisberg and Neilson (32) and Wang et al. (33).”
Background
ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells
Yeung, T.-L., Leung, C. S., Wong, K., Gutierrez‐Hartmann, A., Kwong, J., Gershenson, D. M., & Mok, S. C. (2017) · Oncotarget · doi:10.18632/oncotarget.15208 · Cited by 115
Wnt signaling induces epithelial–mesenchymal transition with proliferation in ARPE-19 cells upon loss of contact inhibition
Chen, H., Zhu, Y., Chen, S., & Tseng, S. C. G. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2011.201 · Cited by 111
Epigenetic Events Associated with Breast Cancer and Their Prevention by Dietary Components Targeting the Epigenome
Khan, S. I., Aumsuwan, P., Khan, I. A., Walker, L., & Dasmahapatra, A. K. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200378c · Cited by 118
Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer
Deng, J., Wang, L., Chen, H., Hao, J., Ni, J., Chang, L., Duan, W., Graham, P., & Li, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.9908 · Cited by 115
Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial–mesenchymal transition and stemness
Wu, K., Ning, Z., Zeng, J., Fan, J., Zhou, J., Zhang, T., Zhang, L., Chen, Y., Gao, Y., Wang, B., et al. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.08.028 · Cited by 115
Liver fibrogenic cells
Forbes, S. J., & Parola, M. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2011.02.006 · Cited by 115
Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer
Papadaki, M. A., Kallergi, G., Zafeiriou, Z., Manouras, L., Theodoropoulos, P. A., Mavroudis, D., Georgoulias, V., & Agelaki, S. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-651 · Cited by 113
“In the present study we developed a new methodology using the ARIOL system, in order to evaluate the protein expression pattern of a putative stemness (ALDH1) and an EMT (TWIST) marker on CTCs of early and metastatic breast cancer patients.”
BackgroundInfluential
The inducible deletion of Drosha and microRNAs in mature podocytes results in a collapsing glomerulopathy
Zhdanova, O. A., Srivastava, S., Di, L., Li, Z., Tchelebi, L. T., Dworkin, S., Johnstone, D. B., Zavadil, J., Chong, M. M. W., Littman, D. R., et al. (2011) · Kidney International · doi:10.1038/ki.2011.122 · Cited by 117
“Rather, it has now been proposed that analyzing changes in expression of a number of different markers, including cytoskelatal proteins, transcription factors, matrix proteins, cell surface receptors, and miRNAs, are required to identify cells undergoing EMT.(50) So far, we have been unable to demonstrate expression o…”
Epithelial–mesenchymal transition involved in pulmonary fibrosis induced by multi-walled carbon nanotubes via TGF-beta/Smad signaling pathway
Chen, T., Nie, H., Gao, X., Yang, J., Pu, J., Chen, Z., Cui, X., Wang, Y., Wang, H., & Jia, G. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.02.004 · Cited by 115
Loss and Recovery of Mgat3 and GnT-III Mediated E-cadherin N-glycosylation Is a Mechanism Involved in Epithelial-Mesenchymal-Epithelial Transitions
Pinho, S. S., Oliveira, P., Cabral, J., Carvalho, S., Huntsman, D. D., Gärtner, F., Seruca, R., Reis, C. A., & Oliveíra, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033191 · Cited by 113
“This is valid for EMT, but also to the apparent reverse process known as Mesenchymal to Epithelial Transition (MET), that occurs during embryonic development, tissue regeneration, wound-healing and thought to occur in cancer initiation/ progression [18,19,20].”
Background
MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis
Dutta, P., Sarkissyan, M., Paico, K., Wu, Y., & Vadgama, J. V. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4760-8 · Cited by 115
“Those markers are well known as EMT-associated markers [17].”
Background
Prospects for new lung cancer treatments that target EMT signaling
Otsuki, Y., Saya, H., & Arima, Y. (2017) · Developmental Dynamics · doi:10.1002/dvdy.24596 · Cited by 113
Irisin inhibits pancreatic cancer cell growth via the AMPK-mTOR pathway
Liu, J., Song, N., Yi, H., & Chen, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-33229-w · Cited by 116
Thymic fatness and approaches to enhance thymopoietic fitness in aging
Dixit, V. D. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.06.010 · Cited by 115
“Recent data suggest that CR efficiently blocks EMT and age-related increase in pro-adipogenic machinery in thymus (26).”
BackgroundInfluential
Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of β-catenin expression
Lin, D. C.-C., Kuang, G., Wan, J., Zhang, X., Li, H., Gong, X., & Li, H. (2016) · Oncology Reports · doi:10.3892/or.2016.5311 · Cited by 113
“From a molecular viewpoint, EMT is characterized by downregulation of epithelial cell markers such as E-cadherin and claudin, and upregulation of mesenchymal molecules such as vimentin and N-cadherin (5,6).”
BackgroundInfluential
Ellagic acid inhibits human pancreatic cancer growth in Balb c nude mice
Zhao, M., Tang, S., Marsh, J. L., Shankar, S., & Srivastava, R. K. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.05.009 · Cited by 111
“Tumor cells undergoing EMT are also known to increase the secretion of specific factors, including cytokines, chemokines and growth factors, which could play an important role in tumor progression [78–81].”
Background
High Intensity Focused Ultrasound-Responsive and Ultrastable Cerasomal Perfluorocarbon Nanodroplets for Alleviating Tumor Multidrug Resistance and Epithelial–Mesenchymal Transition
Ma, X., Yao, M., Shi, J., Li, X., Gao, Y., Luo, Q., Hou, R., Liang, X., & Wang, F. (2020) · ACS Nano · doi:10.1021/acsnano.0c07287 · Cited by 110
Protective effect of epigallocatechin-3-gallate (EGCG) via Nrf2 pathway against oxalate-induced epithelial mesenchymal transition (EMT) of renal tubular cells
Kanlaya, R., Khamchun, S., Kapincharanon, C., & Thongboonkerd, V. (2016) · Scientific Reports · doi:10.1038/srep30233 · Cited by 110
MiR-424-5p reversed epithelial-mesenchymal transition of anchorage-independent HCC cells by directly targeting ICAT and suppressed HCC progression
Zhang, Y., Li, T., Guo, P., Kang, J., Wei, Q., Jia, X., Zhao, W., Huai, W., Qiu, Y., Sun, L., et al. (2014) · Scientific Reports · doi:10.1038/srep06248 · Cited by 109
Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines
Tsubaki, M., Komai, M., Fujimoto, S.-I., Itoh, T., Imano, M., Sakamoto, K., Shimaoka, H., Takeda, T., Ogawa, N., Mashimo, K., et al. (2013) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-32-62 · Cited by 109
“EMT entails the downregulation of E-cadherin and the upregulation of its suppressor, Snail and Twist, in carcinoma cells [5,6,10].”
Background
Systematic review of the old and new concepts in the epithelial-mesenchymal transition of colorectal cancer
Gurzu, S., Silveanu, C., Fetykó, A., Butiurcă, V. O., Kovács, Z., & Jung, I. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i30.6764 · Cited by 112
PD-L1 Expression Promotes Epithelial to Mesenchymal Transition in Human Esophageal Cancer
Chen, L., Xiong, Y., Li, J., Zheng, X. W., Zhou, Q., Turner, A., Wu, C., Lu, B., & Jiang, J. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000480000 · Cited by 114
Role of metastasis-induced protein S100A4 in human non-tumor pathophysiologies
Fei, F., Qu, J., Li, C., Wang, X., Li, Y., & Zhang, S. (2017) · Cell & Bioscience · doi:10.1186/s13578-017-0191-1 · Cited by 110
“Type III EMT is part of the metastatic process in which epithelial carcinoma cells in their primary nodule forms migrate to a distant site via blood circulation to reform as a secondary tumor nodule [34].”
Background
TRPV 4 regulates matrix stiffness and TGF β1‐induced epithelial‐mesenchymal transition
Sharma, S., Goswami, R., Zhang, D. X., & Rahaman, S. O. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13972 · Cited by 108
“The increased expression of YAP and TAZ proteins may modulate nuclear availability of these proteins under multiple pathophysiological conditions.(52-60) Here, we found that TRPV4 deletion blocked both matrix stiffness‐induced and TGFβ1‐induced expression of YAP and TAZ proteins in NMEKs, suggesting an additional mech…”
BackgroundInfluential
Mouse Models of Human Gastric Cancer Subtypes With Stomach-Specific CreERT2-Mediated Pathway Alterations
Seidlitz, T., Chen, Y., Uhlemann, H., Schölch, S., Kochall, S., Merker, S. R., Klimová, A., Hennig, A., Schweitzer, C., Pape, K., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.09.026 · Cited by 110
hnRNP A2/B1 Modulates Epithelial-Mesenchymal Transition in Lung Cancer Cell Lines
Tauler, J., Zudaire, E., Liu, H., Shih, J. H., & Mulshine, J. L. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0860 · Cited by 110
The role of epithelial to mesenchymal transition in resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer
Jakobsen, K. R., Demuth, C., Sørensen, B. S., & Nielsen, A. L. (2016) · Translational Lung Cancer Research · doi:10.21037/tlcr.2016.04.07 · Cited by 112
E-Cadherin in Pancreatic Ductal Adenocarcinoma: A Multifaceted Actor during EMT
Sommariva, M., & Gagliano, N. (2020) · Cells · doi:10.3390/cells9041040 · Cited by 112
New Advances in the Research of Resistance to Neoadjuvant Chemotherapy in Breast Cancer
An, J., Peng, C. Y., Tang, H., Liu, X., & Peng, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179644 · Cited by 111
Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer
West, N. R., Murray, J. I., & Watson, P. H. (2013) · Oncogene · doi:10.1038/onc.2013.105 · Cited by 114
Fibrosis in the lens. Sprouty regulation of TGFβ-signaling prevents lens EMT leading to cataract
Lovicu, F. J., Shin, E. H. H., & McAvoy, J. W. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.02.004 · Cited by 108
“…such as cytokeratin and ZO-1, loss of E-cadherin and expression of transcription factors including Snail (Snai1), Slug (Snai2) and Twist (Figure 2; Zeisberg and Neilson, 2009). αSMA is a common marker of active fibroblasts, but it is not specific for fibroblasts (Zeisberg and Neilson, 2009).”
Background
Role of microRNA/Epithelial-to-Mesenchymal Transition Axis in the Metastasis of Bladder Cancer
Ashrafizadeh, M., Hushmandi, K., Hashemi, M., Akbari, M. E., Kubatka, P., Raei, M., Koklesová, L., Shahinozzaman, M., Mohammadinejad, R., Najafi, M., et al. (2020) · Biomolecules · doi:10.3390/biom10081159 · Cited by 108
FSP1+ Fibroblasts Promote Skin Carcinogenesis by Maintaining MCP-1-Mediated Macrophage Infiltration and Chronic Inflammation
Zhang, J., Chen, L., Xiao, M., Wang, C., & Qin, Z. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.11.017 · Cited by 108
ZEB2 upregulates integrin α5 expression through cooperation with Sp1 to induce invasion during epithelial–mesenchymal transition of human cancer cells
Nam, E.-H., Lee, Y., Park, Y., Lee, S. E., & Kim, S. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs005 · Cited by 106
Intestinal Mesenchymal Cells
Pinchuk, I. V., Mifflin, R. C., Saada, J. I., & Powell, D. W. (2010) · Current Gastroenterology Reports · doi:10.1007/s11894-010-0135-y · Cited by 113
“Epithelial to mesenchymal transition (EMT) occurs during embryonic development and during cancer tumorigenesis and metastasis [ 16 ].”
Background
Tumor-promoting functions of transforming growth factor-β in progression of cancer
Miyazono, K., Ehata, S., & Koinuma, D. (2011) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2011.638729 · Cited by 106
Cholesterol Induces Epithelial-to-Mesenchymal Transition of Prostate Cancer Cells by Suppressing Degradation of EGFR through APMAP
Jiang, S., Wang, X., Song, D., Liu, X., Gu, Y., Xu, Z., Wang, X., Zhang, X., Ye, Q., Tong, Z., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3295 · Cited by 106
MYC as a Multifaceted Regulator of Tumor Microenvironment Leading to Metastasis
Meškytė, E. M., Keskas, S., & Ciribilli, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207710 · Cited by 109
Epithelial-mesenchymal transitions and hepatocarcinogenesis
Jou, J. H., & Diehl, A. M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42615 · Cited by 105
HNRNPAB Induces Epithelial–Mesenchymal Transition and Promotes Metastasis of Hepatocellular Carcinoma by Transcriptionally Activating SNAIL
Zhou, Z., Dai, Z., Zhou, S., Hu, Z., Chen, Q., Zhao, Y., Shi, Y., Gao, Q., Wu, W., Qiu, S., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2509 · Cited by 103
“EMT is observed in subsets of carcinoma cells undergoing phenotypic conversion for invasion and metastasis and is characterized by the loss of epithelial cell junction proteins, such as E-cadherin, and the gain of mesenchymal markers, such as vimentin and N-cadherin (36).”
Background
The Cancer Stem Cell Hypothesis: A Guide to Potential Molecular Targets
Allegra, A., Alonci, A., Penna, G., Innao, V., Gerace, D. G., Rotondo, F., & Musolino, C. (2014) · Cancer Investigation · doi:10.3109/07357907.2014.958231 · Cited by 107
“enchymal (N-cadherin expression, mesenchymal morphology, enhanced migration abilities) (111,112).”
Background
Antitumor and Anti-Invasive Effect of Apigenin on Human Breast Carcinoma through Suppression of IL-6 Expression
Lee, H. H., Jung, J., Moon, A., Kang, H., & Cho, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133143 · Cited by 101
“Cancer cells undergoing the EMT process exhibit upregulated expression of N-cadherin, vimentin, fibronectin, and snail and downregulated expression of E-cadherin [60].”
BackgroundInfluential
The Roles of Epithelial-to-Mesenchymal Transition (EMT) and Mesenchymal-to-Epithelial Transition (MET) in Breast Cancer Bone Metastasis: Potential Targets for Prevention and Treatment
Demirkan, B. (2013) · Journal of Clinical Medicine · doi:10.3390/jcm2040264 · Cited by 102
“Type 3 EMT also occurs in adult tissues and involves the mesenchymal transition of epithelial carcinoma cells, leading to generation of metastatic tumor cells [38].”
Background
Gefitinib-mediated Reactive Oxygen Specie (ROS) Instigates Mitochondrial Dysfunction and Drug Resistance in Lung Cancer Cells
Okon, I. S., Coughlan, K. A., Zhang, M., Wang, Q., & Zou, M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.631580 · Cited by 102
“Consistent with EMT, the formation of motile cells from parental cells that lack such motility have been shown to be a hallmark of invasive and metastatic phenotypes displayed by tumors (12, 16, 17).”
Background
Involvement of matrix metalloproteinase-2 in the development of renal interstitial fibrosis in mouse obstructive nephropathy
Du, X., Shimizu, A., Masuda, Y., Kuwahara, N., Arai, T., Kataoka, M., Uchiyama, M., Kaneko, T., Akimoto, T., Iino, Y., et al. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.68 · Cited by 102
Endothelial Induced EMT in Breast Epithelial Cells with Stem Cell Properties
Sigurðsson, V., Hilmarsdóttir, B., Sigmundsdóttir, H., Fridriksdottir, A. J., Ringnér, M., Villadsen, R., Borg, Å., Agnarsson, B. A., Petersen, O. W., Magnússon, M. K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023833 · Cited by 108
“creased mobility and an invasive phenotype [3,4,5].”
Proteomic Signatures of the Desmoplastic Invasion Front Reveal Collagen Type XII as a Marker of Myofibroblastic Differentiation During Colorectal Cancer Metastasis
Karagiannis, G. S., Petraki, C. D., Prassas, I., Saraon, P., Musrap, N., Dimitromanolakis, A., & Diamandis, E. P. (2012) · Oncotarget · doi:10.18632/oncotarget.451 · Cited by 103
Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer
Xu, Q., Sun, Q., Zhang, J., Yu, J., Chen, W., & Zhang, Z. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs374 · Cited by 101
Evidence for and against epithelial-to-mesenchymal transition in the liver
Xie, G., & Diehl, A. M. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00289.2013 · Cited by 98
“EMT has been categorized into three different subtypes based on the biological context in which it occurs: development and organogenesis (type 1); wound healing, tissue, regeneration and organ fibrosis (type 2); and carcinogenesis (type 3) (28, 29, 94).”
BackgroundInfluential
Epithelial–mesenchymal transition and mesenchymal–epithelial transition via regulation of ZEB‐1 and ZEB‐2 expression in pancreatic cancer
Kurahara, H., Takao, S., Maemura, K., Mataki, Y., Kuwahata, T., Maeda, K., Ding, Q., Sakoda, M., Iino, S., Ishigami, S., et al. (2011) · Journal of Surgical Oncology · doi:10.1002/jso.23020 · Cited by 101
“Activation of the EMT program, in which cancer cells acquire a mesenchymal phenotype, has been proposed as the critical mechanism for the progression of epithelial cancer cells [3,4].”
Background
Inflammation Fuels Tumor Progress and Metastasis
Liu, J., Lin, P. C., & Zhou, B. P. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150514105741 · Cited by 103
GZMKhigh CD8+ T effector memory cells are associated with CD15high neutrophil abundance in non-metastatic colorectal tumors and predict poor clinical outcome
Tiberti, S., Catozzi, C., Croci, O., Ballerini, M., Cagnina, D., Soriani, C., Scirgolea, C., Gong, Z., He, J.-T., Macandog, A. D. G., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34467-3 · Cited by 103
Histone deacetylase inhibitor induction of epithelial–mesenchymal transitions via up-regulation of Snail facilitates cancer progression
Jiang, G., Wang, H., Zhang, F., Zhang, K.-S., Liu, Z., Fang, R., Wang, H., Cai, S., & Du, J. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.12.002 · Cited by 99
Slug regulates the Dll4-Notch-VEGFR2 axis to control endothelial cell activation and angiogenesis
Hultgren, N. W., Fang, J. S., Ziegler, M. E., Ramírez, R. N., Phan, D. T. T., Hatch, M. M. S., Welch, K. M., Paniagua, A. E., Kim, L. S., Shon, N. N., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18633-z · Cited by 104
Epithelial-to-mesenchymal transition and stem cells in endometrial cancer
Mirantes, C., Espinosa, Í., Ferrer, I., Dolcet, X., Prat, J., & Matías‐Guiu, X. (2013) · Human Pathology · doi:10.1016/j.humpath.2013.04.009 · Cited by 102
“This EMT promotes the interaction of tumor cells with the stroma, thus facilitating invasion and metastasis [17,18].”
Background
Cancer of the Pancreas: Molecular Pathways and Current Advancement in Treatment
Polireddy, K., & Chen, Q. (2016) · Journal of Cancer · doi:10.7150/jca.14922 · Cited by 103
“During type 3 EMT, some cells retain epithelial traits while acquiring mesenchymal features and other cells shed most epithelial features and become fully mesenchymal (45, 46).”
Background
Hypoxia Stimulates the EMT of Gastric Cancer Cells through Autocrine TGFβ Signaling
Matsuoka, J., Yashiro, M., Doi, Y., Fuyuhiro, Y., Kato, Y., Shinto, O., Noda, S., Kashiwagi, S., Aomatsu, N., Hirakawa, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062310 · Cited by 98
“In epithelial cancers, EMT is recognized as one of the mechanisms responsible for initiating the invasive and metastatic behaviors [3–5].”
Background
The contribution of epithelial-mesenchymal transition to renal fibrosis differs among kidney disease models
Inoue, T., Umezawa, A., Takenaka, T., Suzuki, H., & Okada, H. (2014) · Kidney International · doi:10.1038/ki.2014.235 · Cited by 97
Invasive Prostate Carcinoma Driven by c-Src and Androgen Receptor Synergy
Cai, H., Babić, I., Wei, X. X., Huang, J., & Witte, O. N. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1605 · Cited by 97
The Derivation of Mesenchymal Stem Cells from Human Embryonic Stem Cells
Brown, S. E., Tong, W., & Krebsbach, P. H. (2008) · Cells Tissues Organs · doi:10.1159/000151746 · Cited by 97
“This was described as one of the three EMT subtypes that occurs, and is also suggested to be an underlying mechanism for derivation of hESC-MSCs (Zeisberg and Neilson, 2009; Ullmann et al., 2007).”
Background
Common pathogenic mechanisms and pathways in the development of COPD and lung cancer
Yang, I. A., Relan, V., Wright, C. M., Davidson, M. R., Sriram, K. B., Francis, S. M. S., Clarke, B. E., Duhig, E., Bowman, R., & Fong, K. M. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.555400 · Cited by 99
“2 Epithelial--mesenchymal transition Epithelial--mesenchymal transition (EMT) represents a process in which cells with epithelial phenotype transform into cells with mesenchymal phenotype [39].”
Background
KLF5 Activates MicroRNA 200 Transcription To Maintain Epithelial Characteristics and Prevent Induced Epithelial-Mesenchymal Transition in Epithelial Cells
Zhang, B., Zhang, Z., Xia, S., Xing, C., Ci, X., Li, X., Zhao, R., Tian, S., Ma, G., Zhu, Z., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00787-13 · Cited by 97
Histone Deacetylases as New Therapeutic Targets in Triple-negative Breast Cancer: Progress and Promises
Garmpis, N., Damaskos, C., Garmpi, A., Kalampokas, E., Kalampokas, T., Spartalis, E. D., Daskalopoulou, A., Valsami, S. I., Kontos, M. C., Nonni, A., et al. (2017) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20041 · Cited by 96
Kindlin-2 Mediates Activation of TGF-β/Smad Signaling and Renal Fibrosis
Wei, X., Xia, Y., Li, F., Tang, Y., Nie, J., Liu, Y., Zhou, Z., Zhang, H., & Hou, F. F. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012101041 · Cited by 98
MiR-30a-5p Suppresses Tumor Metastasis of Human Colorectal Cancer by Targeting ITGB3
Wei, W., Yang, Y., Cai, J. Q., Cui, K., Li, R. X., Wang, H., Shang, X., & Wei, D. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000447823 · Cited by 95
“Reduced expression of the epithelial-specific marker E-cadherin, accompanied by increased expression of the mesenchymal-specific marker vimentin, is indicative of EMT (Zeisberg and Neilson, 2009).”
Background
Retracted
Elevation of YAP promotes the epithelial-mesenchymal transition and tumor aggressiveness in colorectal cancer
Ling, H., Kuo, C.-C., Lin, B.-X., Huang, Y., & Lin, C. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.11.024 · Cited by 94
ZFP281 drives a mesenchymal-like dormancy program in early disseminated breast cancer cells that prevents metastatic outgrowth in the lung
Nobre, A. R., Dalla, E., Yang, J., Huang, X., Wullkopf, L., Risson, E., Razghandi, P., Anton, M. L., Zheng, W., Seoane, J. A., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00424-8 · Cited by 98
α-Solanine Inhibits Invasion of Human Prostate Cancer Cell by Suppressing Epithelial-Mesenchymal Transition and MMPs Expression
Shen, K., Liao, A. C.-H., Hung, J., Lee, W.-J., Hu, K.-C., Lin, P.-T., Liao, R.-F., & Chen, P.-S. (2014) · Molecules · doi:10.3390/molecules190811896 · Cited by 95
“is typically characterized by decrease in expression of epithelial markers such as E-cadherin, and increase in expression of mesenchymal markers such as vimentin [18].”
Background
Epithelial-Mesenchymal Transition (EMT) and Regulation of EMT Factors by Steroid Nuclear Receptors in Breast Cancer: A Review and in Silico Investigation
Voutsadakis, I. A. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5010011 · Cited by 94
“Cells undergoing EMT, in addition to losing inter-cellular junctions, lose epithelial cell polarity, gain a fibroblast-like shape, down-regulate epithelial markers such as E-cadherin, claudins, occludins and cytokeratins, and up-regulate mesenchymal markers such as S100A4 (also called FSP1(Fibroblast-Specific Protein…”
Epithelial-mesenchymal, mesenchymal-epithelial, and endothelial-mesenchymal transitions in malignant tumors: An update
Gurzu, S. (2015) · World Journal of Clinical Cases · doi:10.12998/wjcc.v3.i5.393 · Cited by 97
Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma: Identification, Characterization and Clinical Implications
Peitzsch, C., Nathansen, J., Schniewind, S. I., Schwarz, F. M., & Dubrovska, A. (2019) · Cancers · doi:10.3390/cancers11050616 · Cited by 97
Sarcomatoid renal cell carcinoma is an example of epithelial–mesenchymal transition
Conant, J. L., Peng, Z., Evans, M. F., Naud, S. J., & Cooper, K. (2011) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2011-200216 · Cited by 94
The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics
Boesch, M., Zeimet, A. G., Reimer, D., Schmidt, S. U., Gastl, G. A., Parson, W., Spoeck, F., Hatina, J., Wolf, D. G. F., & Sopper, S. (2014) · Oncotarget · doi:10.18632/oncotarget.2053 · Cited by 93
BCL6 induces EMT by promoting the ZEB1-mediated transcription repression of E-cadherin in breast cancer cells
Yu, J., Sun, W., Hua, F., Xie, J., Lin, H., Zhou, D., & Hu, Z. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.05.029 · Cited by 93
KDM5B histone demethylase controls epithelial-mesenchymal transition of cancer cells by regulating the expression of the microRNA-200 family
Enkhbaatar, Z., Terashima, M., Oktyabri, D., Tange, S., Ishimura, A., Yano, S., & Suzuki, T. (2013) · Cell Cycle · doi:10.4161/cc.25142 · Cited by 93
“We further examined the status of actin in the cells by TRITC-conjugated phalloidin staining, since actin reorganization occurs during the EMT process.(17) In contrast to untreated cells (Fig.”
Background
Hypoxia Accelerates Aggressiveness of Hepatocellular Carcinoma Cells Involving Oxidative Stress, Epithelial-Mesenchymal Transition and Non-Canonical Hedgehog Signaling
Liu, Z., Tu, K., Wang, Y., Yao, B., Li, Q., Wang, L., Dou, C., Liu, Q., & Zheng, X. M. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000485821 · Cited by 94
Resistance to Anti-angiogenic Therapies: A Mechanism Depending on the Time of Exposure to the Drugs
Montemagno, C., & Pagès, G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00584 · Cited by 100
“During the EMT process, epithelial cells lose their phenotypes, with a downregulation of E-cadherin and α-catenin and acquire mesenchymal markers (N-cadherin, vimentin, fibronectin) leading to cell mobility and invasiveness (Zeisberg and Neilson, 2009).”
Background
Autophagy attenuates tubulointerstital fibrosis through regulating transforming growth factor-β and NLRP3 inflammasome signaling pathway
Nam, S. A., Kim, W.-Y., Kim, J. W., Park, S. H., Kim, H. L., Lee, M.-S., Komatsu, M., Ha, H., Lim, J. H., Park, C. W., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1356-0 · Cited by 92
Recent advances in understanding inflammation and remodeling in the airways in chronic obstructive pulmonary disease
Sohal, S. S., Ward, C., Danial, W., Wood-Baker, R. R., & Walters, E. H. (2013) · Expert Review of Respiratory Medicine · doi:10.1586/ers.13.26 · Cited by 92
SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody–Drug Conjugate, Shows Antitumor Activity in Uterine Serous Carcinoma with HER2/Neu Expression
Black, J., Menderes, G., Bellone, S., Schwab, C. L., Bonazzoli, E., Ferrari, F., Predolini, F., de Haydu, C., Cocco, E., Buza, N., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0163 · Cited by 91
Emergence of the Phosphoinositide 3-Kinase-Akt- Mammalian Target of Rapamycin Axis in Transforming Growth Factor-β-Induced Epithelial-Mesenchymal Transition
Lamouille, S., & Derynck, R. (2010) · Cells Tissues Organs · doi:10.1159/000320172 · Cited by 96
RETRACTED ARTICLE: LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer
Sun, J., Hu, J., Wang, G., Yang, Z., Zhao, C., Zhang, X., & Wang, J. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0771-x · Cited by 91
“Besides, during EMT, epithelial marker Ecadherin is downregulated, and mesenchymal markers vimentin and N-cadherin are upregulated through regulating different EMT-related signaling pathways [7].”
Background
Retracted
Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer
Kong, F., Qu, Z., YUAN, H.-H., Wang, J., Zhao, M., Guo, Y., SHI, J., Gong, X., Zhu, Y., Liu, F., et al. (2014) · Oncology Reports · doi:10.3892/or.2014.3129 · Cited by 91
ROS induces epithelial‑mesenchymal transition via the TGF‑β1/PI3K/Akt/mTOR pathway in diabetic nephropathy
Lü, Q., Wang, W., Zhang, M., Ma, Z., Qiu, X., Shen, M., & Yin, X. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.7014 · Cited by 90
Molecular Signaling in Tumorigenesis of Gastric Cancer
Molaei, F., Forghanifard, M. M., Fahim, Y., & Abbaszadegan, M. R. (2018) · Iranian Biomedical Journal · doi:10.29252/ibj.22.4.217 · Cited by 90
Regulation of Epithelial-Mesenchymal Transition by Transmission of Mechanical Stress through Epithelial Tissues
Gjorevski, N., Boghaert, E., & Nelson, C. M. (2011) · Cancer Microenvironment · doi:10.1007/s12307-011-0076-5 · Cited by 93
“Changes in gene expression associated with EMT include down-regulation of epithelial markers including E-cadherin and upregulation of mesenchymal markers including vimentin, α-smooth muscle actin, N-cadherin, and fibronectin [ 31 ].”
Background
Electrospun Fibrous Scaffolds Promote Breast Cancer Cell Alignment and Epithelial–Mesenchymal Transition
Saha, S., Duan, X., Wu, L., Lo, P., Chen, H., & Wang, Q. (2011) · Langmuir · doi:10.1021/la203846w · Cited by 90

Authors: Zeisberg, M., & Neilson, E. G.
Affiliations: Beth Israel Deaconess Medical Center (US)
Vanderbilt University (US)
ORCID: Zeisberg, Michael
Neilson, Eric G.
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2009-06-01
Volume: 119
Issue: 6
Pages: 1429-1437
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci36183
PMC: PMC2689132
OpenAlex: W1996118868
Cited by: 2,299
References: 124
Citations by year: 2026: 50 · 2025: 79 · 2024: 127 · 2023: 113 · 2022: 146 · 2021: 148 · 2020: 180 · 2019: 163 · 2018: 170 · 2017: 189 · 2016: 153 · 2015: 162 · 2014: 162 · 2013: 149 · 2012: 109
FWCI: 8.93
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute of Diabetes and Digestive and Kidney Diseases (R03DK081687, R01DK046282, DK46282, K08DK074558, DK-081687, DK074558)
Topics: Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
Keywords: epithelial-mesenchymal transition, cellular plasticity, epithelial cells, endothelial cells, cell motility
MeSH terms: Animals, Cell Differentiation, Epithelial Cells, Fibroblasts, Humans, Neoplasms, Biomarkers, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Biomarkers for epithelial-mesenchymal transitions

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks